Mogamulizumab-kpkc Intravenous and Morphine Oral Concentrate (20 mg/mL)
Determining the interaction of Mogamulizumab-kpkc Intravenous and Morphine Oral Concentrate (20 mg/mL) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
Generic Name: morphine
Brand name: Arymo ER, Kadian, MorphaBond ER, MS Contin, Avinza, Duramorph PF, Infumorph, Mitigo, RMS, Roxanol
Synonyms: Morphine, Morphine (Systemic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Mogamulizumab-kpkc Intravenous-Morphine Oral Solution
- Mogamulizumab-kpkc Intravenous-Morphine Sulfate
- Mogamulizumab-kpkc Intravenous-Morphine Sulfate Injection
- Mogamulizumab-kpkc Intravenous-Morphine Sulfate Injection, Concentrate
- Mogamulizumab-kpkc Intravenous-Morphine Sulfate Solution, Concentrate
- Mogamulizumab-kpkc Intravenous-Morphine Sulfate Suppository
- Morphine Oral Concentrate (20 mg/mL)-Molindone
- Morphine Oral Concentrate (20 mg/mL)-Mometasone (Oral Inhalation)
- Morphine Oral Concentrate (20 mg/mL)-Mometasone and Formoterol
- Morphine Oral Concentrate (20 mg/mL)-Mometasone and formoterol Inhalation
- Morphine Oral Concentrate (20 mg/mL)-Mometasone Cream
- Morphine Oral Concentrate (20 mg/mL)-Mometasone Furoate